Acurx Pharmaceuticals Inc... (ACXP)
0.72
-0.01 (-1.37%)
At close: Jan 30, 2025, 12:52 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -14.58M | -12.09M | -12.75M | -4.60M | -5.93M |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 3.77M | 3.30M | 6.74M | 1.27M | 900.43K |
| Other Working Capital | 30.02K | 30.35K | -387.84M | -801.17K | 1.05M |
| Other Non-Cash Items | 980.75K | 3.30M | 850.26K | 781.70K | 900.43K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 30.02K | 1.25M | 141.28K | -801.17K | 1.05M |
| Operating Cash Flow | -9.80M | -7.54M | -5.01M | -3.35M | -3.99M |
| Capital Expenditures | 5.00 | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 66.50K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.22M | 13.00 | n/a | n/a | n/a |
| Financial Cash Flow | 8.16M | 3.70M | 14.80M | 4.04M | 4.46M |
| Net Cash Flow | -1.64M | -3.85M | 9.78M | 692.09K | 470.17K |
| Free Cash Flow | -9.80M | -7.54M | -5.01M | -3.35M | -3.99M |